Semaglutide for psoriasis and weight management
Treatments studied
Part of Hormones & metabolism, Skin clinical trials.
This trial tests if semaglutide, a diabetes and weight-loss medication, can improve psoriasis symptoms and reduce inflammation. It may be an option for people with both psoriasis and overweight or obesity, with or without diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults 18 years or older with plaque psoriasis affecting at least 3% of body surface area
- Overweight or obese, with a body mass index (BMI) of 25 or higher
- Have not used systemic psoriasis treatments (like methotrexate) for at least 8 weeks
- Have not used biologic therapies (like adalimumab) for at least 3 months
- People with diabetes must have stable medication and an A1C level of 9% or less
- Must not have certain other health issues like severe kidney, liver, heart problems, or history of pancreatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if semaglutide, a medicine used for diabetes and weight loss, can help people with both psoriasis and obesity. You may qualify if you have moderate to severe psoriasis, a high body weight, and are of Chinese descent.
This study tests whether a medication called semaglutide, which is used for weight loss, works better for people who also have binge eating. It aims to find the best treatment based on brain and behavior differences.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This study tests whether a medicine called a GLP-1 receptor agonist (a type of drug often used for weight and diabetes) can help people with psoriatic arthritis who are overweight but not diabetic. It may reduce joint symptoms and help with weight loss.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.